葡萄糖胺补充剂减轻了与代谢功能障碍相关的脂肪性肝病和相关并发症的进展
Tom Ryu1, Young Chang1, Jeong-Ju Yoo2
1Department of Internal Medicine, Institute for Digestive Research, Digestive Disease Center, Soonchunhyang University College of Medicine, Seoul 04401, Republic of Korea.
Clinical nutrition (Edinburgh, Scotland)
|February 28, 2025
概括
葡萄糖胺补充剂显著降低了与代谢功能障碍相关的脂肪性肝病 (MASLD) 患者的死亡率和肝硬化. 它还降低了MASLD和代谢功能障碍和与酒精有关的肝病 (MetALD) 患者的心血管疾病和慢性病风险.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 代谢障碍 代谢障碍 代谢障碍
- 药理学 药理学是指药理学的学科.
背景情况:
- 代谢功能障碍相关的脂肪性肝病 (MASLD) 和代谢功能障碍和酒精相关的肝病 (MetALD) 是严重的健康问题.
- 了解这些疾病的治疗干预措施对于改善患者的治疗结果至关重要.
研究的目的:
- 研究葡萄糖胺对MASLD和MetALD的进展和结果的影响.
- 评估葡萄糖胺对死亡率,肝硬化,心血管疾病,脑血管疾病和慢性病 (CKD) 的影响.
主要方法:
- 进行了一项大规模的队列研究.
- 治疗权重的反向概率 (IPTW) 用于混调整.
- 考克斯的比例危险模型分析了包括全因死亡率,肝硬化,心血管疾病,脑血管疾病和CKD发病率在内的结果.
主要成果:
- 葡萄糖胺在MASLD和MetALD队列中显著降低了全因死亡率.
- 葡萄糖胺的使用与MASLD中肝硬化发病率较低有关.
- 在MASLD和MetALD队列中观察到心血管疾病风险降低,并在MASLD队列中减少CKD发病率.
结论:
- 葡萄糖胺可以作为一种有益的补充疗法,用于脂肪性肝病.
- 患有心血管和脏并发症高风险的患者可能特别受益.
- 需要进一步的临床试验来证实这些发现.
相关概念视频
01:24Overview of Lipid Metabolism
925
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
925
01:29Chronic Pancreatitis II: Collaborative Care
56
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
56